Trial NCT01980875

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-312-0118
Secondary IDs: 2013-004551-20

Last trial update was posted on 2018-11-19

MeSH Interventions

Chlorambucil Idelalisib Obinutuzumab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Chronic Lymphocytic Leukemia

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated in agreement with the FDA due to urgent safety measures. Complete data were not collected for any participant.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID